Relationship between xanthine oxidase gene polymorphisms and anti-tuberculosis drug-induced liver injury in a Chinese population

被引:4
|
作者
Ai, Xin [1 ]
Huang, Hangxing [1 ]
Miao, Zhimin [1 ]
Zhou, Tao [1 ]
Wu, He [1 ]
Lai, Yong [1 ]
机构
[1] Dali Univ, Coll Pharm, Dept Pharmacol, 32 Jia Shi Bo Ave, Dali 671000, Yunnan, Peoples R China
关键词
Anti-tuberculosis drug; Liver injury; Genetic  polymorphism; Xanthine oxidase; Drug metabolizing enzymes; INDUCED HEPATOTOXICITY; N-ACETYLTRANSFERASE-2; GENE; MOLECULAR-CLONING; ADVERSE EVENTS; RISK-FACTORS; PYRAZINAMIDE; ASSOCIATION; METABOLITES; EXPRESSION; HEPATITIS;
D O I
10.1016/j.meegid.2021.104991
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study was designed to investigate the association of the xanthine oxidase (XO) polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury (ATDILI) in Chinese population. A total of 183 tuberculosis patients were enrolled. Patients with ATDILI were classified as cases and those without ATDILI were classified as controls. Genotyping for XO polymorphisms was determined by polymerase chain reaction and direct sequencing. The allele frequencies and genotype distribution was analyzed using the Chi square test to analyze the association between the gene polymorphisms and ATDILI. Binary logistic regression analysis was performed to assess the risk factors of ATDILI. A total of 21 patients were developed liver injury during antituberculosis treatment in this study, with an incidence of 11.48%. In genotype analysis, no significant difference was observed in the alleles and genotypes frequencies of the six SNPs between two groups (P 0.05). In haplotype analysis, carriers with GGGATA (rs1884725- rs2295475 -rs45523133- rs206812- rs206813rs7575607) haplotype had a significantly higher risk of ATDILI compared with other haplotypes (OR = 2.445, 95%CI: 1.058-5.652, P < 0.05). This study suggested that the haplotype GGGATA constructed with rs206812 and rs7575607 mutant alleles might contribute to ATDILI susceptibility in a Chinese population.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis
    Wang, P-Y.
    Xie, S-Y.
    Hao, Q.
    Zhang, C.
    Jiang, B-F.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (05) : 589 - 595
  • [2] Association of POR and PPARα polymorphisms with risk of anti-tuberculosis drug-induced liver injury in Western Chinese Han population
    Zhang, Chunying
    Jiao, Lin
    Bai, Hao
    Zhao, Zhenzhen
    Hu, Xuejiao
    Wang, Minjin
    Wu, Tao
    Peng, Wu
    Liu, Tangyuheng
    Song, Jiajia
    Zhou, Juan
    Li, Mengjiao
    Lyv, Mengyuan
    Zhang, Jingwei
    Chen, Hao
    Chen, Jie
    Ying, Binwu
    INFECTION GENETICS AND EVOLUTION, 2020, 79
  • [3] Transforming growth factor-beta 1 polymorphisms and anti-tuberculosis drug-induced liver injury. Polymorphisms in TGFβ1 and its relationship with anti-tuberculosis drug-induced liver injury
    Wu, Shouquan
    Wang, Yu
    Zhang, Miaomiao
    Wang, Minggui
    He, Jian-Qing
    THERAPIE, 2019, 74 (03): : 399 - 406
  • [4] The relationship between metabolic enzyme genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity
    Sun, Shu-Feng
    Ren, Qi
    Zheng, Guo-Ying
    Han, Tie-Sheng
    Feng, Fu-Min
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (04): : 4321 - 4329
  • [5] Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population
    Wang, Yu
    Xiang, Xi
    Wu, Shou-Quan
    Chen, Guo
    Zhang, Miao-Miao
    Wang, Ming-Gui
    Wang, Feng-Juan
    Sandford, Andrew J.
    He, Jian-Qing
    INFECTION GENETICS AND EVOLUTION, 2017, 51 : 198 - 202
  • [6] Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury
    Devarbhavi, Harshad
    Singh, Rajvir
    Patil, Mallikarjun
    Sheth, Keyur
    Adarsh, Channagiri Krishnamurthy
    Balaraju, Girisha
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (01) : 161 - 167
  • [7] Genetic polymorphisms and anti-tuberculosis drug-induced liver injury: an umbrella review of the evidence
    Cheng, Jingru
    Zhu, Jia
    Chen, Ruina
    Zhang, Meiling
    Han, Bing
    Zhu, Min
    He, Yiwen
    Yi, Honggang
    Tang, Shaowen
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2025, : 624 - 639
  • [8] NAT2 genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Chinese community population
    Lv, Xiaozhen
    Tang, Shaowen
    Xia, Yinyin
    Zhang, Yuan
    Wu, Shanshan
    Yang, Zhirong
    Li, Xiaoting
    Tu, Dehua
    Chen, Yixin
    Deng, Peiyuan
    Ma, Yu
    Chen, Dafang
    Chen, Ru
    Zhan, Siyan
    ANNALS OF HEPATOLOGY, 2012, 11 (05) : 700 - 707
  • [9] Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GST
    Santos, Eliana Abreu
    Saraiva Goncalves, Jose Carlos
    Fleury, Marcos K.
    Kritski, Afranio L.
    Oliveira, Martha M.
    Velasque, Luciane S.
    Lapa e Silva, Jose Roberto
    Estrela, Rita de Cassia E.
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2019, 23 (06) : 381 - 387
  • [10] Association of ABCG2 polymorphisms with susceptibility to anti-tuberculosis drug-induced hepatotoxicity in the Chinese population
    Wang, Nannan
    Chen, Xinyu
    Hao, Zhuolu
    Yi, Honggang
    Tang, Shaowen
    XENOBIOTICA, 2022, 52 (05) : 527 - 533